Thank you to our wonderful speakers and attendees who made this such a great inaugural seminar! Stay tuned for news on the 2023 event! Scroll down to see photos from the day.

Organizing Theme: Activation of  Regulatory T Cells for Induction of Immune Tolerance

Interest in therapeutics specifically for inducing and activating Tregs by various approaches including  administration of Tregitopes, is growing, and we see the need for an annual meeting for academic and industry researchers to share ideas, create new collaborations and continue to expand this growing therapeutic area.

Session 1: Treg cells as Therapeutics
Chair: Dr. David Scott, Uniformed Services University Health System

Session 2: Therapeutics to Induce/Activate Tregs
Chair: Dr. Amy Rosenberg, EpiVax


Annie De Groot,  EpiVax, Inc.
Clare Baecher-Allan,  Harvard Medical School
David Scott, Uniformed Services University of the Health Sciences
Arjan Stoppelenburg, Utrecht University
Bruce Mazer, The Research Institute of The McGill University Health Centre
Marieme Dembele, McGill University
Andres Gutiérrez, EpiVax, Inc.
Nadia Tchao, Amgen
Shah Miah, EpiVax, Inc.